BioCatalyst

ONC-392 low, ONC-392 high, lutetium Lu 177 vipivotide tetraxetan — catalyst calendar

1 verified catalyst event(s) referencing ONC-392 low, ONC-392 high, lutetium Lu 177 vipivotide tetraxetan, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-30
in 4mo
ESTIMATED
 READOUT
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
Phase 1/2 · Metastatic Castration-resistant Prostate Cancer
 OncoC4, Inc. ONC-392 low, ONC-392 high, lutetium Lu 1 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.